公司资料
Adverum Biotechnologies 股价、新闻与催化剂
- 股票代码:
- ADVM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for ADVM.
公司概览
业务概览
Adverum Biotechnologies is a gene-therapy company focused on ophthalmology and retinal disease. Its story centers on whether durable ocular gene therapy can create value in a difficult but high-unmet-need space.
所在地与行业分类
Adverum is headquartered in the United States and listed on NASDAQ. It sits in gene therapy and ophthalmology biotechnology.
商业模式特征
The company depends on clinical and safety data, vector and manufacturing execution, and the ability to keep a narrow ocular pipeline funded. Investors watch readouts and strategic progress closely.
生物医药行业定位
Adverum occupies a specialized ophthalmic gene-therapy niche within biotech. The stock is catalyst-sensitive because the platform still needs to prove a strong and durable safety-efficacy balance.
未来催化剂
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。